CA9 and nonpapillary renal cell carcinoma: The effect of sunitinib in drug-sensitive ccRCC xenografts was associated with increased levels of CAIX and cleaved caspase-3 immunostaining, whereas ccRCC xenografts that did not respond to sunitinib showed no changes in these markers.